# Trade Mark Journal No.2026/032 7 August 2026

## WO0000001929459 (5,10,42,44)

Office of origin: United States of America

Date of International Registration:19 May 2026
Date of designation in the UK: 19 May 2026

International priority date claimed: 2 December 2025 (United States of America) (99524753)
International priority date claimed: 2 December 2025 (United States of America) (99524772)
International priority date claimed: 2 December 2025 (United States of America) (99524775)
International priority date claimed: 2 December 2025 (United States of America) (99524779)

Class 5
  Cultures of microorganisms for medical or veterinary use; medical preparations for the treatment of wounds, aging, inflammation, and degenerative conditions; pharmaceutical and biological preparations for the treatment of wounds, aging, inflammation, and degenerative conditions; stem cells for medical purposes; chemical, biological, and diagnostic reagents for medical use; prepared cell culture media for clinical or medical purposes.
Class 10
  Surgical apparatus and instruments for medical, dental, or veterinary use; injection needles for medical use; inhalers for medical use, sold empty; genetic testing apparatus for medical purposes; apparatus for DNA and RNA testing for medical purposes.
Class 42
  Tissue engineering research; medical and scientific research services in the field of tissue engineering; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research and development in the fields of synthetic biology, molecular biology, genetic engineering, and bioinformatics; genetic mapping for scientific purposes; genetic testing of laboratory animals for research purposes; biomedical research services.
Class 44
  Medical and pharmaceutical consultation; genetic testing for medical purposes; regenerative medicine services; DNA screening for medical purposes; provision of medical services by healthcare professionals via the internet or telecommunication networks; medical services; hygienic and beauty care services; genetic testing of animals for diagnostic or treatment purposes; diagnostic services, namely, medical testing for diagnostic or treatment purposes in the fields of aging, inflammation, degenerative conditions, and other diseases and disorders.

Axagon Bio, Inc.

Representative: Kristin S. Cornuelle Orrick, Herrington & Sutcliffe LLP, 2050 Main Street, Suite 1100, Irvine CA 92614, UNITED STATES OF AMERICA